Advances in Understanding the Links between Metabolism and Autophagy in Acute Myeloid Leukemia: From Biology to Therapeutic Targeting

• Published in: Cells (Basel, Switzerland) Vol. 12; no. 11; p. 1553
• Main Authors: Saulle, Ernestina, Spinello, Isabella, Quaranta, Maria Teresa, Labbaye, Catherine
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 05.06.2023; MDPI
• Subjects: Acute myeloid leukemia; Autophagy; Autophagy (Cytology); Cell death; Cell metabolism; Cell self-renewal; Cell survival; Chemoresistance; Chemotherapy; Cytoplasm; Energy; Enzymes; hematopoiesis; Hematopoietic stem cells; Homeostasis; Kinases; Leukemia; Leukemia research; Medical prognosis; Metabolism; Methods; MicroRNAs; Molecular targeted therapy; Mutation; Phosphorylation; Progenitor cells; Proteins; Review; Stem cells; Therapeutic targets; therapy resistance; Italy; hematopoiesis; metabolism; autophagy; acute myeloid leukemia; therapy resistance
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12111553

Autophagy is a highly conserved cellular degradation process that regulates cellular metabolism and homeostasis under normal and pathophysiological conditions. Autophagy and metabolism are linked in the hematopoietic system, playing a fundamental role in the self-renewal, survival, and differentiation of hematopoietic stem and progenitor cells, and in cell death, particularly affecting the cellular fate of the hematopoietic stem cell pool. In leukemia, autophagy sustains leukemic cell growth, contributes to survival of leukemic stem cells and chemotherapy resistance. The high frequency of disease relapse caused by relapse-initiating leukemic cells resistant to therapy occurs in acute myeloid leukemia (AML), and depends on the AML subtypes and treatments used. Targeting autophagy may represent a promising strategy to overcome therapeutic resistance in AML, for which prognosis remains poor. In this review, we illustrate the role of autophagy and the impact of its deregulation on the metabolism of normal and leukemic hematopoietic cells. We report updates on the contribution of autophagy to AML development and relapse, and the latest evidence indicating autophagy-related genes as potential prognostic predictors and drivers of AML. We review the recent advances in autophagy manipulation, combined with various anti-leukemia therapies, for an effective autophagy-targeted therapy for AML.